Uptake of Combination Antiretroviral Therapy and HIV Disease Progression According to Geographical Origin in Seroconverters in Europe, Canada, and Australia
Author(s) -
Inmaculada Jarrín,
Nikos Pantazis,
M. John Gill,
Ronald B. Geskus,
Santiago PérezHoyos,
Laurence Meyer,
Maria Prins,
Giota Touloumi,
Margaret Johnson,
Osamah Hamouda,
Patricia García de Olalla,
Kholoud Porter,
Julia del Amo
Publication year - 2011
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cir814
Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , disease , sida , virology , immunology , viral disease , demography , environmental health , viral load , sociology
We examined differences by geographical origin (GO) in time from HIV seroconversion (SC) to AIDS, death, and initiation of antiretroviral therapy (cART).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom